What is XOMAO's health score?

XOMA Royalty Corp (XOMAO) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is XOMAO's estimated fair value?

Based on our 5-year discounted cash flow model, XOMA Royalty Corp's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is XOMAO undervalued or overvalued?

Our model currently rates XOMAO as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for XOMAO... Refresh in a moment for the full analysis.

XOMA Royalty Corp (XOMAO)

Healthcare Inconclusive inconclusive weak

Updated: 2026-06-05

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

50 Mixed

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

50 Mixed

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.